Hadi H. Diab
Sdr. Boulevard 29
Odense C, 5000, Denmark
Odense C, 5000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.
Journal: BMC cancer
Published: March 21, 2025
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma.
Journal: Frontiers in molecular biosciences
Published: February 03, 2023
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.
Journal: Cells
Published: September 30, 2022
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
Journal: Biomolecules
Published: August 19, 2022
Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors.
Journal: International journal of molecular sciences
Published: March 18, 2022
The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 02, 2021
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma.
Journal: International journal of cancer
Published: January 12, 2021
Computed tomography scan based prediction of the vulnerable carotid plaque.
Journal: BMC medical imaging
Published: June 19, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026